Stockreport

Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program [Yahoo! Finance]

Precision BioSciences, Inc.  (DTIL) 
Last precision biosciences, inc. earnings: 11/12 07:15 am Check Earnings Report
PDF DURHAM, N.C., March 11, 2026 BUSINESS WIRE )--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® [Read more]